Evidence map›Paper›PMID 35415692›Full record

ArticleFood chemistry. Molecular sciences2022

Muinat M Adeyanju, Idris A Saheed, Oluwaseun I Oyelekan, Taiwo A Dele-Osibanjo, Ayodeji A Adelegan, Adekunle J Raimi, Samuel O Olalekan, Olugbenga S Alabi, Khadijat M Alli

Open access · goldAbstract read
In one paragraph

Article in Food chemistry. Molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Hypertrophic cardiomyopathy: insights into pathophysiology and novel therapeutic strategies from clinical studies.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2025
    Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Muinat M AdeyanjuDepartment of Biochemistry, Faculty of Basic Medical Sciences, Obafemi Awolowo College of Health Sciences, Olabisi Onabanjo University, Ago-Iwoye, Nigeria.
Idris A SaheedDepartment of Biochemistry, Faculty of Basic Medical Sciences, Obafemi Awolowo College of Health Sciences, Olabisi Onabanjo University, Ago-Iwoye, Nigeria.
Oluwaseun I OyelekanDepartment of Biochemistry, Faculty of Basic Medical Sciences, Obafemi Awolowo College of Health Sciences, Olabisi Onabanjo University, Ago-Iwoye, Nigeria.
Taiwo A Dele-OsibanjoDepartment of Biochemistry, University of Medical Sciences, Laje, Ondo City, Ondo State, Nigeria.
Ayodeji A AdeleganDepartment of Biochemistry, Faculty of Basic Medical Sciences, Obafemi Awolowo College of Health Sciences, Olabisi Onabanjo University, Ago-Iwoye, Nigeria.
Adekunle J RaimiDepartment of Biochemistry, Faculty of Basic Medical Sciences, Obafemi Awolowo College of Health Sciences, Olabisi Onabanjo University, Ago-Iwoye, Nigeria.
Samuel O OlalekanDepartment of Physiology, Faculty of Basic Medical Sciences, Obafemi Awolowo College of Health Sciences, Olabisi Onabanjo University, Ago-Iwoye, Nigeria.
Olugbenga S AlabiDepartment of Internal Medicine, Olabisi Onabanjo University Teaching Hospital, Sagamu, Ogun State, Nigeria.
Khadijat M AlliDepartment of Internal Medicine, Olabisi Onabanjo University Teaching Hospital, Sagamu, Ogun State, Nigeria.
Olabisi Onabanjo University · NGOlabisi Onabanjo University Teaching Hospital · NGOndo State University of Science and Technology · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiovascular diseases and metabolic complications caused by hyperlipidemia are the leading cause of death globally

Indexed as

AMPK, adenosine monophosphate-activated protein kinaseCardiovascular diseaseCD36, cluster of differentiation 36CholesterolCPT1, carnitinepalmitoyltransferase-1CVD, cardiovascular diseaseHDL-C, high-density lipoprotein-cholesterolHDL, high density lipoproteinHDL-PL, high-density lipoprotein-phospholipidHDL-TG, high-density lipoprotein-triglycerideHFD, high fat dietHMG-CoA, 3-Hydroxy-3-methyl glutaryl-coenzyme AHMG-CoA reductaseHyperlipidemiaLDL, low density lipoproteinNCD, non-communicable diseasePPAR-α, peroxisome proliferator-activated receptor-αSesamum indicumSI, Sesamum indicumSREBP1, sterol regulatory element binding protein-1TC, total cholesterolUCP2, uncoupling protein 2VLDL, very low-density lipoprotein

Identifiers

PMID35415692
PMCPMC8991713
OpenAlexW4220740917

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.